Literature DB >> 33547160

Pan-Cancer Analysis of Ligand-Receptor Cross-talk in the Tumor Microenvironment.

Umesh Ghoshdastider1, Neha Rohatgi1, Marjan Mojtabavi Naeini1, Probhonjon Baruah1, Egor Revkov1, Yu Amanda Guo1, Simone Rizzetto1, Angeline M L Wong1, Sundar Solai1, Tin T Nguyen1, Joe Poh Sheng Yeong2,3,4, Jabed Iqbal2, Puay Hoon Tan2,5,6, Balram Chowbay7,8,9, Ramanuj Dasgupta1, Anders J Skanderup10.   

Abstract

Signaling between cancer and nonmalignant (stromal) cells in the tumor microenvironment (TME) is a key to tumor progression. Here, we deconvoluted bulk tumor transcriptomes to infer cross-talk between ligands and receptors on cancer and stromal cells in the TME of 20 solid tumor types. This approach recovered known transcriptional hallmarks of cancer and stromal cells and was concordant with single-cell, in situ hybridization and IHC data. Inferred autocrine cancer cell interactions varied between tissues but often converged on Ephrin, BMP, and FGFR-signaling pathways. Analysis of immune checkpoints nominated interactions with high levels of cancer-to-immune cross-talk across distinct tumor types. Strikingly, PD-L1 was found to be highly expressed in stromal rather than cancer cells. Overall, our study presents a new resource for hypothesis generation and exploration of cross-talk in the TME. SIGNIFICANCE: This study provides deconvoluted bulk tumor transcriptomes across multiple cancer types to infer cross-talk in the tumor microenvironment. ©2021 American Association for Cancer Research.

Entities:  

Year:  2021        PMID: 33547160     DOI: 10.1158/0008-5472.CAN-20-2352

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Transcriptome-guided resolution of tumor microenvironment interactions in pheochromocytoma and paraganglioma subtypes.

Authors:  S Batchu; A Hakim; O S Henry; J Madzo; U Atabek; F R Spitz; Y K Hong
Journal:  J Endocrinol Invest       Date:  2022-01-28       Impact factor: 4.256

2.  A systematic pan-cancer analysis identifies RIOK3 as an immunological and prognostic biomarker.

Authors:  Jian Li; Ruili Sun; Lixiang He; Guoyi Sui; Wenyu Di; Jian Yu; Wei Su; Zenggang Pan; Yu Zhang; Jinghang Zhang; Feng Ren
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer.

Authors:  Pratyaksha Wirapati; Nancy Zhao; Zahid Nawaz; Ignasius Joanito; Grace Yeo; Fiona Lee; Christine L P Eng; Dominique Camat Macalinao; Merve Kahraman; Harini Srinivasan; Vairavan Lakshmanan; Sara Verbandt; Petros Tsantoulis; Nicole Gunn; Prasanna Nori Venkatesh; Zhong Wee Poh; Rahul Nahar; Hsueh Ling Janice Oh; Jia Min Loo; Shumei Chia; Lih Feng Cheow; Elsie Cheruba; Michael Thomas Wong; Lindsay Kua; Clarinda Chua; Andy Nguyen; Justin Golovan; Anna Gan; Wan-Jun Lim; Yu Amanda Guo; Choon Kong Yap; Brenda Tay; Yourae Hong; Dawn Qingqing Chong; Aik-Yong Chok; Woong-Yang Park; Shuting Han; Mei Huan Chang; Isaac Seow-En; Cherylin Fu; Ronnie Mathew; Ee-Lin Toh; Lewis Z Hong; Anders Jacobsen Skanderup; Ramanuj DasGupta; Chin-Ann Johnny Ong; Kiat Hon Lim; Emile K W Tan; Si-Lin Koo; Wei Qiang Leow; Sabine Tejpar; Shyam Prabhakar; Iain Beehuat Tan
Journal:  Nat Genet       Date:  2022-06-30       Impact factor: 41.307

4.  Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.

Authors:  Pinzheng Huang; Linfeng Xu; Mingming Jin; Lixi Li; Yizhong Ke; Min Zhang; Kairui Zhang; Kongyao Lu; Gang Huang
Journal:  Genes (Basel)       Date:  2022-05-26       Impact factor: 4.141

5.  Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.

Authors:  Kie-Kyon Huang; Vikrant Kumar; Kalpana Ramnarayanan; Deniz Demircioglu; Zhisheng Her; Raghav Sundar; Xuewen Ong; Zul Fazreen Bin Adam Isa; Manjie Xing; Angie Lay-Keng Tan; David Wai Meng Tai; Su Pin Choo; Weiwei Zhai; Jia Qi Lim; Meghna Das Thakur; Luciana Molinero; Edward Cha; Marcella Fasso; Monica Niger; Filippo Pietrantonio; Jeeyun Lee; Anand D Jeyasekharan; Aditi Qamra; Radhika Patnala; Arne Fabritius; Mark De Simone; Joe Yeong; Cedric Chuan Young Ng; Sun Young Rha; Yukiya Narita; Kei Muro; Yu Amanda Guo; Anders Jacobsen Skanderup; Jimmy Bok Yan So; Wei Peng Yong; Qingfeng Chen; Jonathan Göke; Patrick Tan
Journal:  Gut       Date:  2021-08-25       Impact factor: 31.793

6.  Characterization of cell-cell communication in autistic brains with single-cell transcriptomes.

Authors:  Maider Astorkia; Herbert M Lachman; Deyou Zheng
Journal:  J Neurodev Disord       Date:  2022-05-02       Impact factor: 4.074

7.  Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States.

Authors:  Priya Khurana; Chakkapong Burudpakdee; Stephan A Grupp; Ulf H Beier; David M Barrett; Hamid Bassiri
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

Review 8.  RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics.

Authors:  Poonam R Pandey; Ken H Young; Dhiraj Kumar; Neeraj Jain
Journal:  Mol Cancer       Date:  2022-02-21       Impact factor: 27.401

Review 9.  Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment.

Authors:  Jinfen Wei; Meiling Hu; Hongli Du
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

10.  Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer.

Authors:  Hanqian Zeng; Shiwen Xu; Erjie Xia; Suzita Hirachan; Adheesh Bhandari; Yanyan Shen
Journal:  Aging (Albany NY)       Date:  2021-07-19       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.